HESTERBIO2,270.00

Hester Biosciences Limited

· Pharma & Health
₹ CrorePeersWINDLASSYNCOMFNGLFINEINDOCOSAIPARENTJAGSNPHARMPANACEABIOMcap ₹1,931 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment239.5232.7411.1411.1
+ Capital Work-in-Progress168.1176.7
+ Other Intangibles0.60.60.40.4
+ Intangibles under Development3.36.09.39.3
+ Investments (Equity Method)29.934.140.340.3
+ Non-current Investments0.00.02.32.3
+ Other Non-current Financial Assets3.85.62.32.3
Non-current Financial Assets3.85.64.64.6
+ Other Non-current Assets2.52.63.73.7
Total Non-current Assets447.7458.2469.4469.4
Current Assets
+ Inventories75.670.472.572.5
+ Trade Receivables78.673.295.495.4
+ Cash & Cash Equivalents12.75.62.82.8
+ Other Bank Balances2.61.63.83.8
+ Short-term Loans5.95.80.10.1
+ Other Current Financial Assets18.820.221.021.0
Current Financial Assets118.6106.3123.0123.0
+ Other Current Assets20.518.513.113.1
Total Current Assets214.6195.2208.6208.6
Total Assets662.3653.4677.9677.9
Equity
+ Equity Share Capital8.58.58.58.5
+ Other Equity / Reserves283.3305.7351.7351.7
Equity — Owners of Parent291.8314.3360.2360.2
+ Minority Interest11.112.47.67.6
Total Equity302.9326.7367.8367.8
Liabilities
+ Borrowings — Non-current181.8133.490.090.0
+ Other Non-current Financial Liab8.36.37.37.3
Non-current Financial Liabilities190.1139.697.397.3
+ Provisions — Non-current2.52.82.32.3
+ Deferred Tax Liabilities7.45.98.88.8
+ Other Non-current Liabilities3.73.23.13.1
Non-current Liabilities253.7201.5157.7157.7
+ Borrowings — Current57.374.498.398.3
+ Trade Payables26.429.424.724.7
+ Other Current Financial Liab12.810.414.214.2
Current Financial Liabilities96.5114.2137.2137.2
+ Provisions — Current0.81.01.51.5
+ Current Tax Liabilities2.54.05.05.0
+ Other Current Liabilities6.16.05.25.2
Current Liabilities105.8125.2152.5152.5
Total Liabilities359.5326.7310.2310.2
Total Equity & Liabilities662.3653.4677.9677.9
Liabilities — additional as-filed lines
+ Deferred Government Grants — Current0.00.03.63.6
+ Deferred Government Grants — Non-current50.050.046.146.1
Trade Payables — MSME split
+ Dues to Micro & Small — Current2.56.46.4
+ Dues to Other Creditors — Current26.918.318.3
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.